Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Journal of Cardiovascular Electrophysiology|March 18, 2025
Outcomes in Patients With Mitral Annular Disjunction and an Implantable-Cardioverter DefibrillatorFatima M Ezzeddine, Jee Won Jennifer Shin, Konstantinos C Siontis, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
Palliative care, Version 1.2014. Featured updates to the NCCN GuidelinesMichael H Levy, Thomas Smith, Amy Alvarez-Perez, et al.Blood Advances|February 11, 2026
Halofuginone Suppresses Hepcidin by a Heparan Sulfate-dependent Mechanism to Treat Iron Disorders in MiceStephanie Leal, Andrea Denardo, Anna Van Echten, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 7, 2016
Palliative Care Version 1.2016Michael Levy, Thomas Smith, Amy Alvarez-Perez, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2017
NCCN Guidelines Insights: Palliative Care, Version 2.2017Maria Dans, Thomas Smith, Anthony Back, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Palliative careMichael H Levy, Michael D Adolph, Anthony Back, et al.NPJ Breast Cancer|January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 2, 2021
NCCN Guidelines® Insights: Palliative Care, Version 2.2021Maria Dans, Jean S Kutner, Rajiv Agarwal, et al.Therapeutic Advances in Medical Oncology|September 2, 2022
Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancerElyssa Denault, Erika Nakajima, Vivek Naranbhai, et al.The Lancet. Oncology|April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trialSeth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.Pageof 8